JP2011518787A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518787A5
JP2011518787A5 JP2011505218A JP2011505218A JP2011518787A5 JP 2011518787 A5 JP2011518787 A5 JP 2011518787A5 JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011518787 A5 JP2011518787 A5 JP 2011518787A5
Authority
JP
Japan
Prior art keywords
clonidine
pharmaceutical composition
composition according
target tissue
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505218A
Other languages
English (en)
Other versions
JP2011518787A (ja
Filing date
Publication date
Priority claimed from US12/408,491 external-priority patent/US20090263443A1/en
Application filed filed Critical
Publication of JP2011518787A publication Critical patent/JP2011518787A/ja
Publication of JP2011518787A5 publication Critical patent/JP2011518787A5/ja
Pending legal-status Critical Current

Links

Claims (14)

  1. 手術に付随する筋痙直及び/又は振戦に苦しむ哺乳動物の治療のための医薬組成物であって、前記医薬組成物は、皮下の標的組織部位に投与して該標的組織部位又はその近傍の筋肉を弛緩させるための治療上有効量のクロニジン又はその製薬学的に許容しうる塩を含む、医薬組成物
  2. 前記クロニジンが標的組織部位に薬物デポーとして局所投与される、請求項1に記載の医薬組成物
  3. 薬物デポーが、一定期間にわたってクロニジンを放出するリボン様ファイバーである、請求項1または2に記載の医薬組成物
  4. 前記治療上有効量及び前記放出が、前記筋肉を7〜10日間弛緩させるのに十分である、請求項1〜3のいずれか一項に記載の医薬組成物
  5. 前記投与が、ボーラス用量のクロニジンを標的組織部位に導入することを含む、請求項1〜4のいずれか一項に記載の医薬組成物
  6. 術後の筋痙直及び/又は振戦の治療に有用な組成物であって、術後の手術部位への投与が可能な、有効量のクロニジン又はその製薬学的に許容しうる塩を含む組成物。
  7. 有効量のクロニジン又はその製薬学的に許容しうる塩を埋込み可能な薬物デポー中に含む徐放性組成物であって、前記クロニジン又はその製薬学的に許容しうる塩は、術後筋痙直及び/又は振戦を5〜12日間軽減する量で存在し、前記埋込み可能な薬物デポーは、前記期間にわたってクロニジンの持続放出を促進する徐放性組成物。
  8. 前記期間が7〜10日間である、請求項7に記載の徐放性組成物。
  9. 有効量のクロニジン又はその製薬学的に許容しうる塩を薬物デポー中に含む即時放出組成物であって、前記クロニジン又はその製薬学的に許容しうる塩は、術後筋痙直及び/又は振戦を軽減する量で存在し、前記薬物デポーは、クロニジンの即時放出を促進する量で存在する即時放出組成物。
  10. 手術に付随する筋痙直に苦しむ哺乳動物の治療のための医薬組成物であって、前記医薬組成物は、皮下の標的組織部位に投与して該標的組織部位又はその近傍の筋肉を弛緩させるための治療上有効量のクロニジン又はその製薬学的に許容しうる塩を含み、前記治療上有効量は痙直の発症を防止する、医薬組成物
  11. 前記クロニジンが標的組織部位に薬物デポーとして局所投与される、請求項10に記載の医薬組成物
  12. 薬物デポーが、一定期間にわたってクロニジンを放出するリボン様ファイバーである、請求項10または11に記載の医薬組成物
  13. 前記治療上有効量が、前記筋肉を7〜10日間弛緩させるのに十分である、請求項10〜12のいずれか一項に記載の医薬組成物
  14. 前記投与が、クロニジンの即時放出を提供するためにボーラス用量のクロニジンを標的組織部位に導入することを含む、請求項10〜13のいずれか一項に記載の医薬組成物
JP2011505218A 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法 Pending JP2011518787A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4619208P 2008-04-18 2008-04-18
US61/046,192 2008-04-18
US12/408,491 2009-03-20
US12/408,491 US20090263443A1 (en) 2008-04-18 2009-03-20 Methods for treating post-operative effects such as spasticity and shivering with clondine
PCT/US2009/040885 WO2009129428A2 (en) 2008-04-18 2009-04-17 Methods for treating post-operative effects such as spasticity and shivering with clonidine

Publications (2)

Publication Number Publication Date
JP2011518787A JP2011518787A (ja) 2011-06-30
JP2011518787A5 true JP2011518787A5 (ja) 2012-01-19

Family

ID=41199746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505218A Pending JP2011518787A (ja) 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法

Country Status (5)

Country Link
US (1) US20090263443A1 (ja)
EP (1) EP2207545B1 (ja)
JP (1) JP2011518787A (ja)
CN (1) CN101827592A (ja)
WO (1) WO2009129428A2 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
WO2012075451A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
WO2012075447A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
KR20180054627A (ko) * 2015-09-21 2018-05-24 테바 파마슈티컬스 인터내셔널 게엠베하 서방형 올란자핀 제제
JP2020511483A (ja) 2017-03-20 2020-04-16 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH 徐放性オランザピン製剤
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス, インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
EP0778768B1 (en) * 1995-06-09 2004-05-26 Euroceltique S.A. Formulations and methods for providing prolonged local anesthesia
US6113624A (en) * 1995-10-02 2000-09-05 Ethicon, Inc. Absorbable elastomeric polymer
ATE318580T1 (de) * 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
WO1999058074A2 (en) * 1998-05-12 1999-11-18 Scimed Life Systems, Inc. Manual bone anchor placement devices
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6436099B1 (en) * 1999-04-23 2002-08-20 Sdgi Holdings, Inc. Adjustable spinal tether
US7220281B2 (en) * 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US7329529B2 (en) * 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US7951201B2 (en) * 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
ES2278648T3 (es) * 1999-12-06 2007-08-16 Warsaw Orthopedic, Inc. Dispositivo para tratar un disco intervertebral.
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
US6756058B2 (en) * 2001-01-03 2004-06-29 Bausch & Lomb Incorporated Sustained release drug delivery devices with multiple agents
US7229441B2 (en) * 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US6991597B2 (en) * 2001-03-09 2006-01-31 Boston Scientific Scimed, Inc. System for implanting an implant and method thereof
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6974462B2 (en) * 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
US8133501B2 (en) * 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7345065B2 (en) * 2002-05-21 2008-03-18 Allergan, Inc. Methods and compositions for alleviating pain
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
JP4723244B2 (ja) * 2002-07-19 2011-07-13 オメロス コーポレイション 生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料
US20040166088A1 (en) * 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
CN1822816A (zh) * 2003-05-30 2006-08-23 阿尔萨公司 可植入的弹性体储库组合物、其用途以及制备方法
US7144412B2 (en) * 2003-06-25 2006-12-05 Wolf Medical Enterprises, Inc. Gold suture and method of use in wound closure
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050148512A1 (en) * 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
US20050186261A1 (en) * 2004-01-30 2005-08-25 Angiotech International Ag Compositions and methods for treating contracture
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060074422A1 (en) * 2004-09-27 2006-04-06 Story Brooks J Suture anchor and void filler combination
US20060253100A1 (en) * 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
CN101119713A (zh) * 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20060183786A1 (en) * 2005-02-16 2006-08-17 Chi Mei Foundation Hospital Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
KR101398903B1 (ko) * 2005-05-20 2014-06-19 오메로스 코포레이션 시클로옥시게나제 저해제 및 칼슘채널 길항제 조성물 및 이의 비뇨기과 시술시의 용도를 위한 방법
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
US20080019975A1 (en) * 2006-07-07 2008-01-24 Bioassets Development Corporation Novel Regimens for Treating Diseases and Disorders
US20080091207A1 (en) * 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods

Similar Documents

Publication Publication Date Title
JP2011518787A5 (ja)
EP2032128B1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
WO2009129509A3 (en) Methods and compositions for treating post-operative pain comprising a local anesthetic
JP2020033360A5 (ja)
WO2009129437A3 (en) Methods and compositions for treating post-operative pain comprising clonidine
JP2009542702A5 (ja)
JP2014528901A5 (ja)
WO2012007159A3 (en) Novel gastro-retentive dosage forms
WO2009129210A4 (en) Compositions and methods for treating post-operative pain using clonidine and bupivacaine
WO2010009116A3 (en) Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
US20220142953A1 (en) Lidocaine patch and methods of use thereof
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
GB2435211B (en) Drug delivery system
ES2704987T3 (es) Composiciones farmacéuticas para terapia de combinación
WO2012012347A3 (en) Methods of intravenous administration of glyburide and other drugs
Sivrikaya Multimodal analgesia for postoperative pain management
RU2013127420A (ru) Способы уменьшения психогенного или компульсивного переедания
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
RU2015103107A (ru) Комбинированная композиция
JP2011503212A5 (ja)
MX2007010886A (es) Metodos y formulaciones de acarbosa para tratar constipacion cronica.
IL273715B1 (en) A subcutaneous biodegradable naltrexone implant and a companion behavioral program for patient weight loss
ATE446309T1 (de) Den kapillarwiderstand verbessernde peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu deren anwendung
RU2013157834A (ru) Композиции для подкожного введения физиологически активных средств
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain